Want to see NEO full AI Analyst Report?
NeoGenomics (NEO) Income Statement
NeoGenomics Income Statement
Last quarter (Q3 2026), NeoGenomics's total revenue was $209.25M, an increase of 11.43% from the same quarter last year. In Q3, NeoGenomics's net income was $-7.55M. See NeoGenomics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 727.33M | $ 660.57M | $ 591.64M | $ 509.73M | $ 484.33M | |
| $ 282.54M | $ 290.10M | $ 244.60M | $ 187.90M | $ 187.06M | |
| $ 348.62M | $ 382.21M | $ 352.34M | $ 345.52M | $ 305.81M | |
| Depreciation and Amortization | $ 67.82M | $ 72.55M | $ 72.58M | $ 69.43M | $ 53.35M |
| $ -38.69M | $ -1.51M | $ -17.61M | $ -82.33M | $ 46.50M | |
| $ -66.08M | $ -92.11M | $ -107.74M | $ -157.62M | $ -118.75M | |
| $ -44.19M | $ 11.43M | $ 10.64M | $ -1.72M | $ 103.68M | |
| $ -110.27M | $ -80.67M | $ -97.10M | $ -159.34M | $ -15.07M | |
| $ -108.03M | $ -78.73M | $ -87.97M | $ -144.25M | $ -8.35M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.84 | $ -0.62 | $ -0.70 | $ -1.16 | $ -0.07 |
| Diluted EPS | $ -0.84 | $ -0.62 | $ -0.70 | $ -1.16 | $ -0.07 |
| Weighted Average Shares Outstanding | 128.10M | 126.66M | 125.50M | 124.22M | 119.96M |
| Weighted Average Shares Outstanding (Diluted) | 128.10M | 126.66M | 125.50M | 124.22M | 119.96M |
Currency in USD